ABSTRACT The hepatic pigment accumulated in 3,5-diethoxycarbonyl-1,4-dihydrocollidine-treated rats, which has been reported to inhibit ferrochelatase, has been isolated and purified. The pigment has been resolved into one major, one minor, and two trace components, all of which appear to be isomeric porphyrins. The major fraction has been unambiguously identified byspectroscopic methods as the isomer of N-methyprotoporphyrin IX (isolated as the dimethyl ester) in which vinyl-substituted pyrrole ring A is methylated. The minor product appears to be an isomer of the same porphyrin with the N-methyl group on propionic acid-substituted ring C, and the trace components have the same high-pressure liquid chromatography retention times as the other two possible isomers of the porphyrin. The four isomers of N-methylprotoporphyrin LX have been chemically synthesized, independently characterized, and used to confirm the structures of the biological products.
The heuristic perturbation of hepatic heme synthesis by chemical agents has played a pivotal role in elucidation of the heme biosynthetic pathway and of the mechanism through which it is regulated. Two agents, allylisopropylacetamide (AIA) and 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC), have achieved particular prominence in this regard because the biosynthetic derangements that they engender mimic in many respects the inherited metabolic defects characteristic of certain human porphyrias (1) . Administration of DDC to animals results in inhibition of the hepatic mitochondrial ferrochelatase responsible for the insertion of iron into the porphyrin ligand and consequently leads to the accumulation of protoporphyrin IX (2) (3) (4) . Direct inhibition of ferrochelatase by DDC, however, appears not to be involved because the enzyme is not inhibited in vitro by this agent (2, 3) . The mechanism of the inhibitory interaction has therefore remained obscure.
More than a decade ago, two independent groups observed a rapid decrease in hepatic cytochrome P-450 levels in mice treated with either AIA or DDC (5, 6) . Subsequent studies established that AIA-mediated loss of cytochrome P-450 reflected conversion of the enzyme prosthetic heme into an abnormal green pigment (7, 8) . We have established that the prosthetic heme is alkylated by an activated form of AIA produced during catalytic processing of this substrate, and we have demonstrated that the AIA green pigment is a covalent adduct of AIA with protoporphyrin IX (9) (10) (11) . The interaction of DDC with cytochrome P-450, in contrast to the interaction of AIA with this enzyme, has not been intensively investigated. Tephly, Gibbs, and De Matteis, however, have recently reported that a green hepatic pigment is also formed in DDC-treated mice (12, 13) and have made the further important discovery that this pigment, unlike that obtained with AIA, is a potent inhibitor of mitochondrial ferrochelatase (13, 14) . The differential physiological effects of AIA and DDC are thus related, at least in part, to differences in the structures of the accompanying hepatic pigments. In concert with our efforts to define the structure of the abnormal porphyrins due to AIA and other unsaturated agents (9, 10, 15, 16) , we have undertaken a structural investigation of the DDC-induced pigment. We report here unambiguous spectroscopic identification of the DDC pigment as N-methylprotoporphyrin IX (dimethyl ester), confirmation of this structural assignment by chemical synthesis of the four possible isomers of the structure, and use of the synthetic isomers to define the ratio of isomers in the biological product.
MATERIALS AND METHODS
Isolation of Abnormal Porphyrins. Sprague-Dawley male rats weighing approximately 250 g received aqueous sodium phenobarbital (80 mg/kg of body weight daily) intraperitoneally for 4 days prior to injection by the same route of DDC (400 mg/ kg) in dimethyl sulfoxide (100 mg/ml). The rats were decapitated 4 hr after DDC injection and their livers were perfused in situ and subsequently homogenized in ice-cold 0.9% saline (1 ml of saline per liver). The resulting homogenate was added to 5% (vol/vol) H2SO4methanol (100 ml per liver) and the mixture was stored at 40C in the dark for [17] [18] [19] [20] hr. Filtration, addition of 0.5 vol of water, and extraction twice with methylene chloride yielded an organic extract, which was washed four times with equal volumes of water before 0.5 ml of methanol saturated with zinc acetate was added. After drying over anhydrous sodium sulfate and removal of the solvent on a rotary evaporator, a crude residue was obtained which was purified by thin-layer chromatography on Analtech (1000 ,um) silica gel G plates using 3:1 (vol/vol) chloroform/acetone. The red-fluorescing fraction (RF 0.4-0.6) was extracted with methanol and was rechromatographed under the same conditions. The purified sample was then subjected to high-pressure liquid chromatography (HPLC) on a 4.6 X 250 mm Partisil 10-PAC (Whatman) column that was eluted with a 20 min 0-100% linear gradient of methanol into 1:1 (vol/vol) hexane/tetrahydrofuran. The zinc-complexed pigment, which migrated as a single peak, was demetalated by passage through 5% (vol/vol) H2SOd methanol (10) . HPLC Fourier transform NMR spectrometer. Generally, a 700 pulse was employed with a repetition time of 1.26 sec and an acqui-II sition time of 1.16 sec. Solutions of the porphyrins in deuterated chloroform were used for NMR studies. The zinc com-III A plexes were washed with sodium chloride solution prior to IV preparation of the solutions for NMR to ensure that chloride was the zinc counterion. All peaks are assigned relative to the chloroform signal at 7.21 ppm. Circular dichroism spectra were obtained in methylene chloride on a Jovan Dichrograph II.
RESULTS
The hepatic pigment formed in rats treated with DDC (400 mg/ kg), after carboxyl group methylation, extraction, and complexation with divalent zinc, was purified by sequential thin-/ ,f'\, layer chromatography and HPLC. A single band or peak was observed for the zinc complex throughout this purification sequence. Removal of the zinc ion from the purified zinc complex, i however, followed by HPLC, led to resolution of the free base 10 14 18 into four relevant peaks ( Fig. 1 ). The second and third of these in time, min peaks (in order of elution from the column) represent most of the isolated material. Of these two peaks, the former is quan-)urified DDC pigment after demettitatively the most important, whereas the first and fourth peaks -) and the mixture of the four synrepresent relatively minor fractions. The ratio of the first two ter of N-methylprotoporphyrin IX peaks to the latter two, all four being due to isomeric porphyrins (-) . The synthetic isomers are numbered, in order of elution, as I-IV. Peaks with retention times of 2-7 min are due to impurities.
complex (saturated methanolic zinc acetate) followed by HPLC purification as described above for the zinc complexes. Synthesis of the N-Methylprotoporphyrin IX (Dimethyl Ester) Isomers. Methylfluorosulfonate (1.0 ml, 12 mmol) and 500 mg of the dimethyl ester of protoporphyrin IX (0. 84 mmol) in dry methylene chloride (50 ml) were stirred in the dark at room temperature for 3 days. After washing with water, drying over anhydrous sodium sulfate, and solvent removal, the product was chromatographed on a 4 x 37 cm column of 10% (wt/ wt) water-deactivated Merck silica gel 60, using 20:1 (vol/vol) chloroform/methanol as the eluting solvent. Unreacted starting porphyrin (75 mg), the dimethyl ester of N-methylprotoporphyrin IX (250 mg), and the dimethyl ester of N,N-dimethylprotoporphyrin IX (50 mg) were eluted, in that order, from the column. The N-monomethylated fraction was then resolved into the four possible isomers of N-methylprotoporphyrin IX by HPLC on a 9.4 X 250 mm Partisil 10-PAC column, using 
were collected and. their electronic absorption spectra, after recomplexation with. zinc, were determined. The spectrum of the zinc-complexed second fraction is given in Fig. 2 (spectrum  A) ; the corresponding spectrum of the third peak (not shown) is superimposable on that reproduced in Fig. 2 (spectrum C) .
The predominant (second) fraction has been subjected to further spectroscopic study. Field desorption mass spectrometric analysis of the free base gave a very clean spectrum with a welldefined molecular ion peak at mass-to-charge ratio (m/e) 605.
The electron impact mass spectrum, also obtainable in this instance, exhibited a molecular ion at m/e 604 with a smaller peak at m/e 606. The latter peak reflects reduction. of the porphyrin within the electron impact source (18) . To determine if the nitrogen atom from DDC was incorporated into the abnormal porphyrin, a possibility suggested by the fact that the m/e 605 molecular ion corresponded to the sum of protoporphyrin IX (dimethyl ester) plus an -NH moiety, '5N-labeled DDC was synthesized. The labeled agent was administered to rats and the principal abnormal porphyrin formed was isolated as before.
The porphyrin gave the same m/e 604 and 606 molecular ion doublet as the porphyrin obtained with unlabeled agent. These results establish that the true molecular ion is at m/e 604, that the field desorption peak at m/e 605 was a monoprotonated molecular ion (M+ + H), and that the DDC nitrogen was not incorporated into the abnormal porphyrin. We have usually observed monoprotonated molecular ions in the field desorption mass spectra of biological adducts (10, 15, 16) .
The principal DDC-derived abnormal porphyrin was recomplexed with zinc and was purified once more by HPLC prior to determination of its NMR spectrum (Fig. 3) . All the protons expected from incorporation of protoporphyrin IX into the abnormal porphyrin can be discerned in the spectrum: four meso protons (10.2-10.4 ppm), two one-proton multiplets due to the internal protons on the vinyl substituents (8.0 and 8.2 ppm), a four-proton multiplet due to the terminal protons on the vinyl groups (6.2-6.4 ppm), eight protons due to the four methylene units in the propionic acid sidechains (4.3 and 3.3 ppm), and six singlets due to the four methyl groups on the ring plus the two methyl ester moieties (3.5-3.7 ppm). Only one other relevant signal appears in the spectrum, a three-proton singlet at -4.5 ppm which is not lost by proton exchange on addition of deuterated water. The extreme upfield position of this signal uniquely identifies it as an N-methyl substituent centered in the ring current of the porphyrin. The additional (extraneous) peaks in the spectrum are due to chloroform (7.21 ppm), an impurity (1.5 ppm), and water (1.2 ppm). Identification of all the protons from the dimethyl ester of protoporphyrin IX and of three N-methyl group protons, two structural components whose molecular weights add up to the observed molecular ion at m/e 604, unambiguously defines the structure of the abnormal porphyrin as N-methylprotoporphyrin IX (dimethyl ester) (Fig. 4) .
Chemical reaction of the dimethyl ester of protoporphyrin IX with methyl fluorosulfonate yielded, after purification and separation by HPLC of the isomers (Fig. 1) Pyrrole ring A is alkylated in the structure.
of the four possible N-methylprotoporphyrin IX dimethyl ester isomers. In order of elution from the HPLC column, these isomers are designated as I-IV. The electronic absorption spectra of the zinc complexes of these isomers differ slightly, the major difference being that the Soret band in isomers I and II (Fig. 2, spectrum B ) has a shoulder at longer wavelengths, IV IIn II whereas this shoulder is not present in the spectra of isomers III and IV (Fig. 2, spectrum C) . The synthetic isomers exhibited a molecular ion at m/e 604 in their field desorption mass spectra even when the spectra were obtained on the same day (and with the same emitter) as the spectrum of the biological adduct. The consistent observation of a monoprotonated (m/e 605) molecular ion with the biological sample must therefore reflect an altered ionization mode due to the presence of trace impurities in the sample. The electron impact spectra of the synthetic and biological samples, however, were identical.
The NMR spectra of the four synthetic isomers (Fig. 5) can be divided into two sets. Isomers I and II are differentiated from isomers III and IV by the presence in the first pair of two distinct internal vinyl proton signals (8.0 and 8.2 ppm) but of only one signal for each of the two types of methylene groups in the propionic acid side chains (3.3 and 4.3 ppm). Isomers III and IV, conversely, exhibit only one internal vinyl proton multiplet but four distinct signals due to the propionic acid side chain methylene groups (4.3, 4.2, 3.3, and 2.9 ppm) . These differences clearly establish that isomers I and II are N-methylated on vinyl-substituted pyrrole rings, whereas isomers III and IV are those methylated on the propionic acid-substituted rings. This follows from the fact that tilting of the N-methylated ring will alter the position of its substituents relative to the ring cur-W~~~ĨI. 1494 Biochemistry: Ortiz de Montellano et alP rent and.cause them to shift upfield in the NMR spectrum relative to similar substituents on the unmethylated pyrrole rings (18) .
Preliminary circular dichroism studies of biologically formed isomers II and III show that these. abnormal porphyrins are optically active. No circular dichroism curves are obtained, of course, with the corresponding synthetic structures because they are racemic mixtures.
DISCUSSION
The esterified pigment from DDC-treated rats has been resolved into four porphyrin components (Fig. 1) , the principal one of which has been unambiguously identified by electronic absorption (Fig. 2, spectrum A) , NMR (Fig. 3) , and mass spectrometric studies as the dimethyl ester of N-methylprotoporphyrin IX. Chemical synthesis of the four possible isomers of this N-methylated porphyrin has allowed independent confirmation of the structural assignment: the retention time on HPLC (Fig 1) , the electronic absorption spectrum (Fig. 2, spectrum B) , and the NMR spectrum (Fig. 5 ) of synthetic isomer II are identical to those of the major biologically formed product. In addition, the minor but still significant.component of the biological sample (the third peak) exhibits the same retention time (Fig. 1 ) and electronic absorption spectrum (Fig. 2 , spectrum C) as synthetic isomer III. The two trace components in the biological sample appear, on the basis of their. retention time, to be isomers I and IV of the N-methylated porphyrin, although their detailed-study has not been possible.
The synthesis and individual characterization of the four Nmethylprotoporphyrin IX isomers have enabled us to establish that isomers I and II have the N-methyl group on the vinyl-substituted pyrrole rings. Isomers III and IV, on the other-hand, are methylated on the propionic acid-substituted pyrrole rings. Isotopic studies combined with NMR relaxation and nuclear Overhauser measurements (details to be reported separately) have established that isomers I, II, III, and IV are N-methylated on rings B, A, C, and D, respectively. The identity of the principal biological product with isomer II thus demonstrates that pyrrole ring A in the heme from which the. adduct is derived is the most vulnerable to N-methylation. However, all four rings appear to be biologically methylated, propionic acid-substituted ring C (that which results in isomer III) being the second most susceptible to N-alkylation.
Correlation of the electronic absorption spectra of isomers I-IV with the type of ring alkylated in each reveals a potentially very useful difference between N-alkylation of vinyl-and propionic acid-substituted rings: a shoulder on the Soret band (Fig.  2, spectrum B) is found in the former but not in the latter (Fig.  2, spectrum C) . If general, this difference provides a simple means for the assignment of the type of ring alkylated in other biological adducts. The findings that alkylation by ethylene of the prosthetic heme of cytochrome P450 (16, 19) yields N-(2-hydroxyethyl) protoporphyrin IX in which the N-alkyl substitutent is on a propionic acid-bearing ring (20) and that the Soret band. of the dimethyl ester of this porphyrin does not have a shoulder support the validity of the proposed spectroscopic correlation. It is also apparent from the difference in the pyrrole ring principally (or exclusively) alkylated in. these two different adducts that there is no universal preference for biological Nalkylation of one type of ring. It is also clear from the observation that the biologically isolated structures are optically active that they must have been formed in a stereoselective process.
Definitive characterization of the DDC-engendered porphyrin fills a critical void in our understanding of the mechanism of action of this porphyrinogenic agent. In conjunction with our studies of the abnormal porphyrins induced by other agents (10, 15, 16) , this investigation also lays the foundation for elucidation of the mechanisms by which the abnormal porphyrins are formed. The origin of the N-methyl group. in the present case and the chain of events that results in, its introduction are intensely interesting questions for two reasons. The first is that, unlike other abnormal porphyrins in which the administered agent becomes the N-alkyl group (10, 15, 16) , it is not evident that the N-methyl group is contributed by the original DDC framework. The second is that a hepatic pigment identical to that induced by DDC has been claimed to be present in untreated mice (12) . If confirmed, it may mean that the formation of N-methylprotoporphyrin IX is a physiological rather than aberrant process. The synthetic availability of the isomers of this porphyrin, described here, should expedite the effective resolution of these problems. 
